News | July 15, 2021
Caplin gets USFDA approval for Sumatriptan
Sumatriptan Injection USP is indicated in adults for acute treatment of migraine with or without aura, and acute treatment of cluster headache
Sumatriptan Injection USP is indicated in adults for acute treatment of migraine with or without aura, and acute treatment of cluster headache
Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
The company has a cumulative total of 147 ANDA approvals (129 final approvals and 18 tentative approvals) from USFDA
Shilpa's Paracetamol oral thin films are patent protected and are first of this kind in the world
Glenmark has been granted a competitive generic therapy (CGT) designation for theophylline extended-release tablets
Aurobindo has one of the most enduring generics ecosystems among peers
This test is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens from individuals suspected of COVID-19
Natco has withdrawn its application filed with the Indian Patent Office, seeking Compulsory License against Lilly for Baricitinib for Covid-19 in India
The trial met its pre-specified primary endpoint, demonstrating that PDP-716 dosed once daily is equivalent to Alphagan P 0.1% dosed 3 times a day
The agreement will help ensure wider reach and access to patients in India
Subscribe To Our Newsletter & Stay Updated
